Pluri Inc. Form DEF 14A: Definitive proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-04-23: Form DEF 14A; Period of report 2026-06-15; Description DEFINITIVE PROXY STATEMENT; Document ea0286813-def14a_pluriinc.htm.
- 2025-05-27: Form DEF 14A; Period of report 2025-06-30; Description DEFINITIVE PROXY STATEMENT; Document ea0243174-def14a_pluriinc.htm.
- 2024-05-01: Form DEF 14A; Period of report 2024-06-25; Description DEFINITIVE PROXY STATEMENT; Document ea0204843-def14a_pluri.htm.
- 2023-02-27: Form DEF 14A; Period of report 2023-04-27; Description DEFINITIVE PROXY STATEMENT; Document ea174285-def14a_pluriinc.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-04-23 | DEF 14A | 2026-06-15 | DEFINITIVE PROXY STATEMENT | ea0286813-def14a_pluriinc.htm |
| 2025-05-27 | DEF 14A | 2025-06-30 | DEFINITIVE PROXY STATEMENT | ea0243174-def14a_pluriinc.htm |
| 2024-05-01 | DEF 14A | 2024-06-25 | DEFINITIVE PROXY STATEMENT | ea0204843-def14a_pluri.htm |
| 2023-02-27 | DEF 14A | 2023-04-27 | DEFINITIVE PROXY STATEMENT | ea174285-def14a_pluriinc.htm |
| 2022-04-27 | DEF 14A | 2022-06-21 | DEFINITIVE PROXY STATEMENT | ea158794-def14a_pluristem.htm |
| 2021-04-08 | DEF 14A | 2021-06-01 | DEFINITIVE PROXY STATEMENT | ea139144-def14a_pluristem.htm |
| 2020-05-20 | DEF 14A | 2020-06-29 | DEFINITIVE PROXY STATEMENT | ea122213-def14a_pluristem.htm |
| 2019-04-25 | DEF 14A | 2019-04-25 | DEF 14A | zk1922966.htm |
| 2018-04-03 | DEF 14A | 2018-04-03 | DEF 14A | zk1821446.htm |
| 2017-03-30 | DEF 14A | 2017-03-30 | DEF 14A | zk1719760.htm |
| 2016-04-04 | DEF 14A | 2016-04-04 | DEF 14A | zk1618299.htm |
| 2015-04-02 | DEF 14A | 2015-04-02 | DEF 14A | zk1516544.htm |
| 2014-03-31 | DEF 14A | 2014-03-31 | DEF14A | zk1414690.htm |
| 2013-03-29 | DEF 14A | 2013-03-29 | DEF 14A | zk1312871.htm |
| 2012-03-22 | DEF 14A | 2012-03-22 | DEF 14A | zk1211200.htm |
| 2011-04-15 | DEF 14A | 2011-04-15 | DEF 14A | zk1109762.htm |
| 2009-11-23 | DEF 14A | 2009-11-23 | Definitive proxy statement | zk97567.htm |
| 2008-12-29 | DEF 14A | 2008-12-29 | Definitive proxy statement | zk86181.htm |
| 2008-06-02 | DEF 14A | 2008-06-02 | Definitive proxy statement | zk85369.htm |
| 2004-01-13 | DEF 14A | 2004-01-13 | Definitive proxy statement | pluristemschedule14a.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |